In 2023, 24.3% of US adults had chronic pain, and 8.5% had high-impact chronic pain (HICP) that frequently limited daily ...

The level of premature death in the U.S. is still unacceptably high. But progress isn’t just about where you are; it’s also ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Shares of Viking Therapeutics VKTX lost 18% yesterday after pharma giant Merck MRK announced its foray into the obesity space ...

Groundbreaking weight-loss drugs like Ozempic and Wegovy have understandably generated a lot of excitement, bringing hope to ...

The NHS has released an online tool to help patients check if they are eligible for certain weight loss medications - use the ...

A new weight loss treatment known as tripeptide (Mounjaro) is expected to be rolled out via the NHS in March 2025 ...

Glucagon-like peptide-1 (GLP-1) type obesity drug craze is hot.Demand for Novo Nordisk's Ozempic, Hugo Bee, and Eli Lilly's ...

Biden officials recently proposed allowing Medicare to start covering GLP-1 medications to treat obesity. It's unclear ...

News of Merck’s licensing of Hansoh’s preclinical medicine pressured shares in Viking and other obesity drug developers seen ...

Merck partners with Hansoh Pharma for GLP-1 drug development, while analysts highlight Viking's obesity assets as key for ...